Full Press Release Details
NEW BRUNSWICK, N.J. , April 20, 2022 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ ) will participate in the UBS Global Healthcare Conference on Tuesday, May 24 th . Mathai Mammen , Executive Vice President, Pharmaceuticals R&D, will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time) .
This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com .
A webcast replay will be available approximately 48 hours after the live webcast.
SOURCE Johnson & Johnson